SARS, MERS and COVID-19, the story continues

Authors

Ata MahmoodpoorAta Mahmoodpoor ORCID1,*
1Anesthesiology department, Faculty of medicine, Tabriz University of Medicicne
*Corresponding Author: Anesthesiology department, Faculty of medicine, Tabriz University of Medicicne Email: [email protected]

Journal of Cellular & Molecular Anesthesia:Vol. 5, issue 2; e149633
Published online:Jul 02, 2020
Article type:Editorial
How to Cite:Mahmoodpoor A. SARS, MERS and COVID-19, the story continues. J Cell Mol Anesth. 2020;5(2):e149633. doi: https://doi.org/10.22037/jcma.v5i2.31196

Abstract

Although the three viruses corona viruses (SARS-CoV: 2003, MERS-CoV: 2012 and SARS-CoV-2: 2019) have similarities especially regarding clinical features, there are key differences between them that limit the relevance of experiences from previous crises. Regarding treatment in the absence of vaccine, it is recommended an the first stage to use pharmaceuticals and their combinations (protease inhibitors, interferon compounds, antiviral antibodies) aiming to suppress diverse targets during virus propagation and during the second disease stage, it seems crucial and reasonable to rely on administration of pathogenetic drugs to restrict life threatening events resulting in marked inflammation, intoxication, hypoxia and infection. The most important method to prevent viral zoonosis is to maintain the barriers between natural reservoirs and human society.

References

  • 1.
    References are in the PDF file of the article.

Copyright

© 2020, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

25
Apr
2020

The Current Clinically Relevant Findings on COVID-19 Pandemic

Joseph V. Pergolizzi Jr.,
Peter Magnusson,
Jo Ann LeQuang,
Frank Breve,
Antonella Paladini,
Martina Rekatsina
,et al.

Pergolizzi Jr. JV, Magnusson P, LeQuang JA, Breve F, Paladini A, et al. The Current Clinically Relevant Findings on COVID-19 Pandemic. Anesth Pain Med. 2020;10(2):e103819. doi: https://doi.org/10.5812/aapm.103819

7
May
2020

COVID-19: Features, clinical course and concerns

Parvaneh Darabi,
Mehrdad Bagherpour kalo,
Kosar Ali,
Saeed Safari,
Mahmoud Yousefifard,
Mostafa Hosseini

Darabi P, Bagherpour kalo M, Ali K, Safari S, Yousefifard M, et al. COVID-19: Features, clinical course and concerns. J Cell Mol Anesth. 2020;5(2):e149613. doi: https://doi.org/10.22037/jcma.v5i2.29885

9
Apr
2020

Insights into the SARS-CoV2 Outbreak; the Great Global Challenge: A Mini Review

Dr Behzad Pourhossain,
Ali Dabbagh,
Maryam Fazeli

Pourhossain DB, Dabbagh A, Fazeli M. Insights into the SARS-CoV2 Outbreak; the Great Global Challenge: A Mini Review. J Cell Mol Anesth. 2020;5(1):e149605. doi: https://doi.org/10.22037/jcma.v5i1.29718

15
Mar
2020
COVID-19: The New Threat

COVID-19: The New Threat

Shaila Rahman,
Tamanna Bahar

Rahman S, Bahar T. COVID-19: The New Threat. Int J Infect. 2020;7(1):e102184. doi: https://doi.org/10.5812/iji.102184

29
Nov
2021
Genetic Path of the Emergence of SARS-CoV-2

Genetic Path of the Emergence of SARS-CoV-2

Taslima Nasrin,
Safdar Ali

Nasrin T, Ali S. Genetic Path of the Emergence of SARS-CoV-2. Gene Cell Tissue. 2022;9(1):e118302. doi: https://doi.org/10.5812/gct.118302

More by these authors

Ata MahmoodpoorPubMedScholar
Share
Cited by
Metrics